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complex gene models. We applied a proteogenomics strategy to detect un-annotated protein-coding regions
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As the post-genomic era gains momentum, identifying protein-
coding genes remains a fundamental challenge in genome annotation
[1]. Historically, data sources based on gene expression (e.g. ESTs
library) have provided valuable information for deﬁning the location
of encoding genes in genome [2–4]. On the other hand, the method of
ab initio gene prediction has been proved to be rather effective in
cataloging prokaryote genomes [5–7]. However, both approaches
have to account for an inevitable deﬁciency that they can not give the
direct evidence of an expressed gene being actually translated into its
protein product or not. In recent years, the strategy of proteoge-
nomics, which uses proteome information to interpret protein-coding
gene models, has been broadly applied to annotate prokaryote and
eukaryote genomes. It can complement previous approaches byindependently and unambiguously identifying the naturally expressed
protein products of the genome, thus provide direct evidences for
characterizing protein-coding genes [1].
According to the typical analysis pipeline of bottom-up proteo-
mics, the essential step of proteogenomics is to build a feature
database containing diagnostic peptide/protein sequences against
which tandem mass spectra data could be searched [8–10]. The
diagnostic peptides identiﬁed were then aligned backwards to the
parent genome to compare with the pre-annotated gene models, to
conﬁrm existent protein-coding genes in public databases, determine
translation start and stop sites, discover new spliced exon junctions
and novel encoded genes [11–13]. In prokaryote genomes, for
example, Link et al. searched tandem mass spectra against a 6-
frame translated Haemophilus inﬂuenza genome for the ﬁrst time.
They found 2 genome loci which were not previously annotated [14].
Ishino et al. integrated a tandem mass proteomic data with a
knowledge system regarding the translation initiation sites in
Synechocystis sp. PCC6803 genome. A total of 14 N-terminal
annotation errors in current gene boundaries were eventually revised
and six probable new candidate ORFs were veriﬁed [15].
As for eukaryote genome, the cassette gene models and the
complex alternative splicing patterns render the application of
proteogenomics far more difﬁcult than for prokaryote genomes.
Still, notable progresses have been achieved in this ﬁeld. Castellina et
al. searched large amount of tandem mass spectrometry data with
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Fig. 1. The analysis pipeline for discovery of novel protein-coding features in mouse
genome by proteogenomics strategy.
344 X.-B. Xing et al. / Genomics 98 (2011) 343–351three different translation frames of the Arabidopsis thaliana genome.
They newly discovered 778 protein-coding genes and reﬁned 695
pre-annotated genes in A. thaliana using more than 140,000
identiﬁed distinct peptides [11]. On the other hand, Merrihew et al.
used a general proteomic method to annotate Caenorhabditis elegans
genome. In total 6010 exon–exon splicing junctions were veriﬁed in
WormBase and 429 new coding sequences were identiﬁed, of which
23 were inferred to represent products of pseudogenes, 152 to reﬁne
errors in gene models and 245 to provide hints of novel gene
discoveries [13]. For human genome, Tanner et al. built a compact
dataset representing all the exons and introns. The queried results
with tandemmass spectra data validated a large number of exons and
introns at the level of translation, discovered novel exons or
extended exons in 16 human genes and found 40 novel alternative
splicing events [12]. Still for human genome, searching against the in
silico translation of entire human genome, Bitton et al. discovered
346 putative human novel peptides, two of which were validated as
novel protein isoforms and the rest were corresponded to novel
genome loci [16].
One of the model organisms, mouse, has been an experimental
subject for many years. Its genome information has undergone
continual updates since the ﬁrst release of its genome sequence
[17]. In the latest release, it was annotated with more than 50,000 full
length proteins from more than 20,000 protein-coding genes
(Ensembl gene 59), and the protein-coding region only took up
about 1% of the whole genome [18]. For sure it is not the ﬁnal version.
Mouse genome annotation had never been tackled with proteoge-
nomics strategy until recently, Brosch et al. inferred 10 novel protein-
coding loci, 31 alternative splicing events and 53 cases of alternative
translation start sites using newly identiﬁed peptides from proteo-
mics analysis [19].
Almost concurrently, we made an effort to deﬁne un-annotated
protein-coding regions in mouse genome using high-accuracy
tandem mass spectra data generated in house. Two diagnostic
datasets of theoretical peptide sequences were constructed based on
mouse genome sequence. In consideration of the cassette model of
exon/intron in eukaryote genes, peptides in one dataset (denoted as
EJCT dataset) represented spliced exon–exon junctions across the
genome, and peptides in the other dataset (denoted as ORF dataset)
covered un-interruptive encoding regions embedded in open
reading frames. Additionally, a non-redundant competitive dataset
(denoted as Annotated dataset) of known mouse proteins was
constructed with full mouse protein sequences from NCBI RefSeq
protein [20], EBI-IPI protein [21] and Ensembl proteins [18].
Combining either EJCT dataset or ORF dataset with Annotated
dataset, two searchable proteomic databases can be composed.
Overall 494 MS/MS raw ﬁles from multiple mouse samples were
queried by X!Tandem against these two databases respectively.
Finally 28,711 known peptides and 875 novel diagnostic peptides
were recovered from both databases through a strict cutoff of
peptide false discovery rate (FDR) at spectrum level. For the novel
peptides, about 27% (235) could be cross referenced in other
independent sources (ESTs library, RNA-Seq data, splicing array
data and homolog information).
Aligning the peptides backwards to the mouse chromosome, 4471
pre-annotated genes (including 296 hypothetical genes) were
conﬁrmed of their translation products by the known peptides, and
172 novel genic events were annotated inmouse genome by the novel
peptides. Speciﬁcally, 88 events could indicate novel ORFs in the un-
interpreted genome region, 52 events were related to new exon
splicing isoforms, 19 events could indicate retained introns to mature
mRNA, 6 events overlapped with pre-annotated 3′/5′ UTR, 2 events
possibly deﬁned two new longer exons than previously located, 3
events updated three “Transcript only” genes into protein-coding
regions, and 2 events veriﬁed translations of two pseudogenes. Our
work pipeline is illustrated in Fig. 1.2. Results
2.1. Generation of tandem mass spectrometry data from mouse samples
In order to achieve a relatively high coverage of mouse proteome,
494 mouse MS raw ﬁles were generated by intensive liquid
chromatography fractionation coupled with high mass accuracy
identiﬁcation with LTQ-Orbitrap mass spectrometer. The samples
were collected from mouse embryonic stem cells, differentiation and
mature 3T3-L1 adipose cells, mouse brain, muscle and liver tissues.
For all of the samples, parallel phosphorylation enrichment was
performed with ion exchange chromatography [22] and/or titanium
dioxide [23]. By including low-abundance phosphoproteins in living
cells, the coverage of proteome identiﬁcation was increased [24].2.2. Construction of two diagnostic databases
For diagnostic peptide discoveries one initial step was to build
extensive proteomic query sequence databases. Since most of
eukaryote genes are modeled by cassette exon/intron(s) in the
genome, the novel protein-coding feature regions could be derived
from (i) novel splice junctions of known exons in annotated genes and
(ii) un-discovered continuous encoding regions located in annotated
genes or in un-interpreted regions in mouse genome. To this end, we
constructed two diagnostic datasets for peptides discovery (See
Materials and methods). EJCT (Exon JunCTion) dataset was built to
discover peptides which could indicate exon junctions in annotated
genes (Supplementary Fig. 1). It included 1,272,627 non-ambiguous
peptide sequences. On the other hand, ORF dataset, preliminarily
obtained by translating mouse genome sequence in six frames to
encompass all possible encoded peptides, was built to discover
potential novel encoding regions from ORF in mouse genome. It
contained 81,371,189 non-ambiguous peptide sequences.
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X!Tandem was chosen as the proteomics search engine in
consideration of i) its high speed, which could be a primary advantage
for querying large database with large amount of tandem mass
spectrometry data, and ii) its probability-based scoring to effectively
evaluate the quality of each mapping between a spectrum and
candidate peptides [25]. The preliminary evaluation hyper score could
be conveniently applied to control the quality of searched peptides.
Target/decoy strategy was adopted to build the input search database
EJCT/ORF for X!Tandem, with the decoy dataset being the reversals of
EJCT/ORF dataset [26]. In the present work, a competitive Annotated
dataset which contained non-redundant mouse full-length protein
sequences from NCBI RefSeq database, EBI-IPI database and Ensembl
protein database, was combined with the target dataset of EJCT/ORF
database and was queried by raw MS ﬁles. The spectrum hyper score
from X!Tandem search results was used to control the local FDR to be
less than 1e−6 at the spectrum level (See Materials and methods).
Search parameters were set as following: fragment monoisotopic mass
error=0.4 Da, parentmonoisotopicmass error=±20 ppm,maximum
missed cleavage sites=1 and modiﬁcation mass=57.022 Da@cystine.
Finally a set of 29,586 unique peptides were identiﬁed, of which 28,636
uniquepeptides (out of 1,029,150 spectra)were fromEJCTdatabase and
17,616 unique peptides (out of 690,243 spectra) were from ORF
database (Supplementary Table 8). Most of the parsed spectra ppm
were distributed in an acceptable range of less than 10 bias
(Supplementary Fig. 2).
2.4. Determination of novel diagnostic peptides
Diagnostic peptide in our work was deﬁned as the peptide with
unique genome locus which could conﬁdently represent a splicing
event of two exons in EJCT dataset or a continuous encoding genome
region in ORF dataset. After FDR control, 23,399 (79%) peptides were
present in both diagnostic EJCT or ORF dataset and Annotated dataset,
which demonstrated the effective coverage and representativeness of
the newly built diagnostic datasets. 1285 (4%) peptides were
identiﬁed only in diagnostic datasets (which could be candidate
novel diagnostic peptides). 4902 (17%) peptides were only present in
Annotated dataset. Using the “both present” peptides as direct
evidences, we conﬁrmed the translation characteristics of 4471
genes, and veriﬁed 296 hypothetical genes by two peptides-per
protein standard (Supplementary Table 1). Further false positives
from the 1285 candidate novel diagnostic peptides were ﬁltered out
by blasting against the Annotated dataset (See Materials and
methods). Eventually, 875 novel diagnostic peptides without any
overlap (2256 spectra) were ﬁnally deﬁned, 284 of which (32%) were
from EJCT dataset (Supplementary Table 2) and 591 (68%) from ORF
dataset (Supplementary Table 3). The complementarity of the two
distinct sets of novel diagnostic peptides proved the necessity of
constructing diagnostic peptide datasets with different approaches.
Out of the 875 novel diagnostic peptides, 235 (27%) peptides were
further cross validated by other independent sources such as
transcript evidences or homology hints from other species, some
peptides were found with multiple evidences. In detail, 212 peptides
were supported by RNA-seq data, 49 by NCBI EST library, and 1 by
splicing microarray data, 22 by blasting with NCBI nr database (See
Materials and methods).
Huttlin et al. built a tissue speciﬁc atlas of mouse proteome
which translationally validated 6194 known mouse genes [27].
Comparing to the 4471 known mouse genes translationally
validated by our analysis, 2186 genes are overlapped (49% of our
result) (Supplementary Table 1).
We also compared our identiﬁed novel peptides with the work of
Brosch et al., which discovered 10 novel protein-coding loci and 31
alternative splicing events in mouse genome by proteogenomicsstrategy [19]. Only one peptide (“DPFAELSLEDFL” in our work and
“AAGKDPFAELSLEDFL” in Brosch et al.) was shared that maps to the
same chromosome position of mouse genome. This is not so
surprising given the fact that the mouse proteome is far from being
saturated by mass spectrometry-based peptide identiﬁcations. More-
over, protein expression occurs only under speciﬁc and transient
cellular and developmental conditions [19]. It is very likely that
different experiments capture different scenarios on complex mouse
proteome. This also implies that there is still a long way to go to reﬁne
protein-coding regions in mouse genome by mass spectrometry.
On the other hand, since we used older versions of NCBI and
Ensembl databases in our original analysis, we recheckedwhether any
of our identiﬁed novel peptides have been incorporated in current
build of these databases.We found out that two of our identiﬁed novel
peptides, one from EJCT dataset “SIFSGIDGLSSADPSSDWNA-
PAEEWGNWVDEDR”, the other from ORF dataset “MASNFIGNSTAI-
QELFK”, have now been incorporated in Mus_musculus.NCBIM37.63
from Ensembl (for details see Materials and methods).
2.5. Inference of genic events at genome level from novel diagnostic
peptides
A total of 176 novel diagnostic peptides (identiﬁed with at least 2
counts) from 875 were selected to infer 172 genic events at genome
level. By their genome loci relative to established gene models, the
events could be classiﬁed into two types: intragenic— the genome loci
of events overlapping within or cross the boundaries of annotated
gene models, and intergenic — the genome loci of events locating in
un-annotated region of mouse genome. The results were summarized
in three categories, i) 52 intragenic events indicated new exon
splicing isoforms, ii) 32 intragenic events reﬁned existent gene
models, and iii) 88 intergenic events provided evidences for novel
protein-coding genes.
2.5.1. Intragenic events to infer novel exon splicing isoforms
In total 52 novel splicing events (involving 47 genes) in the
genome were inferred from 52 novel diagnostic peptides from EJCT
dataset (Supplementary Table 4). The median straddling distance of
newly inferred splicing events was about 214 bp along the chromo-
some, which was about 20 times longer than the median distances of
all known splice events (~210) upon which most prediction
algorithms are based. It could partially explain the reason that these
novel splicing events have not been annotated by ab initio prediction
algorithms, since it is difﬁcult for them to scan the genome sequence
to connect two encoding exons together across a much longer
distance.
For the 52 novel splicing events, 4 (8%) of themwere supported by
ESTs library, 3 (6%) of themwere foundwith homology in nr database,
and 22 (42%) kept the typical domains that existed in their parent
genes (See Materials and methods). For example, 5 novel splicing
events were found in gene Ttn (ENSMUSG00000051747), which gene
was previously annotated with 31 transcripts (27 protein coding) in
Ensembl database. Four of the new events possessed the typical
domains of Ttn, “TITIN”, “Fibronectin, type III”, or “Immunoglobulin”,
indicating at least one more new transcript of gene Ttn was identiﬁed
in our work. Another novel splicing event that has not been annotated
in current public database was represented by the peptide “WEGEDE-
DEDVKLEEPEESK”, which linked the exons of ENSMUSE00000684431
and ENSMUSE00000348770, straddling two middle exons
(ENSMUSE00000684428 and ENSMUSE00000684427) in gene Eif3j
(ENSMUSG00000027236) (Fig. 2A). The transcript evidence from ESTs
library, dbj|AV470456.1|, obviously supported the novel splicing
junction.We also found the homology of the event in species ofMacaca
mulatta (ref|XP_002804798.1|) and Callithrix jacchus (ref|
XP_002753452.1|) from nr database. In addition, all the translation
level evidences contained the typical domain of gene Eif3j, “Translation
Eif3j (ENSMUSG00000027236)
Cdh2 (ENSMUSG00000024304)
A
B
Fig. 2. A) One novel diagnostic peptide “MCTKDSPFSMDYDLSQLQQPDTVEPDAIKPVGIR” represents a new exon splicing event with frame shift. B) A new exon splicing event inferred
from novel diagnostic peptide “RWEGEDEDEDVKLEEPEESK” is cross supported by transcript evidence from EST library and homolog alignment to nr database.
346 X.-B. Xing et al. / Genomics 98 (2011) 343–351initiation factor eIF3 subunit”. The splicing event therefore should reﬁne
the gene annotation of Eif3j by bringing out a novel transcript and the
corresponding novel protein.
In total 8 (15%) frame shift splicing events were detected because
exon phases were disregarded during the construction of EJCT dataset
(SeeMaterials andmethods).Onenewsplicingpeptide,whichstraddled
the exons ENSMUSE00000350907 and ENSMUSE00000315021 of the
gene Cdh2 (ENSMUSG00000024304), was found to be a frame shift
event (Fig. 2B). In Ensembl database, ENSMUSE00000350907 was
translated in Frame +1 and ENSMUSE00000315021 in Frame +2,
however, the detection of the peptide “MCTKDSPFSMDYDLSQLQQPDT-
VEPDAIKPVGIR” suggested that the two exons were joined in order and
translated in Frame +2. The “ATG” in the 5′end of exon
ENSMUSE00000350907 encoded amino acid “M”, which changed the
encoding frame of the exon and made the junction with exon
ENSMUSE00000315021 possible. Frame shift events were also discov-
ered in other works of eukaryotic genome annotation with this similar
strategy [28]. This indicates the superiority of proteogenomics method,
since transcript evidences or ab initio prediction tools can hardly verify
events of coding frame shift.
2.5.2. Intragenic events to reﬁne gene models
Thirty two intragenic events which were discrepant with current
annotation of gene models were discovered, occurring in the regions
of intron (19), exon (2), 3′/5′UTR (6) or regions inside transcript-only
gene (3) or pseudogene (2).
Totally 19 genic events happened within introns. The discoveries of
corresponding peptides of which could provide conﬁdent evidences for
their beingﬁnally translated toproteinproducts (SupplementaryTable5).
However, it was difﬁcult to infer novel transcript isoforms or correct
existing transcript models from these events, because only fragments
could be assembled from peptides to genes. Other independent sources
were in lack of support in these cases, since out of the 19 intronic protein
coding events, only 1 peptide could ﬁnd evidence from ESTs library, 2
peptides could ﬁnd nr homolog alignments. Meanwhile, using the 19
novel peptides as hints to AUGUSTUS (a gene prediction tool which could
integrate other information as hints of nucleotide sequence to improve
accuracy of gene discovery) [29], few could be included into reasonable
exon models. However, even the fragment coding information could
improve gene annotation. For example, one continuous coding regioninferred by the peptide “NPWPKVDAHSGVLLQYNGMLEMNYYTVLFGVSR”
located between the two exons (ENSMUSE00000570078, ENSMUS-
E00000641044) in gene Fam172a (ENSMUSG00000064138, Chr13:
77847983–78305491) (Fig. 3A). Homology evidences from nr database
indicated that the sequence of the coding region was similar to the
corresponding part of one mouse gene “Cs citrate synthase” (Entrez gene
ID: 12974) located on chromosome 10, and its homolog gene in Rattus
norvegicus (Entrez gene ID: 170587) and Bos taurus (Entrez gene ID:
280682). It also contained the typical function domain of gene Cs citrate
synthase, “Citrate synthase”, across the whole coding region. The
evidences here could possibly support a new transcript for gene
Fam172a with the partial coding region containing a domain functioning
similarly like gene Cs citrate synthase.
Two genic events happened to exons. Novel ORFs deﬁned by novel
peptides enclosed existent exons (exon ENSMUSE00000803186 in
gene ENSMUSG00000068036, and exon ENSMUSE00000496808 in
gene ENSMUSG00000063870) (Supplementary Table 5). Because the
exon boundaries had already been supported by other protein
evidences, and there were no changes of the reading frame between
the exons and newly deﬁned ORFs, it was more likely that only new
longer exons were discovered toward 3′ and 5′ ends of previous
annotated exons (extended exons).
For the 6 events that overlapped with the 3′/5′ UTR, it was likely
that they could reﬁne the boundaries of the discrepant genes. Most
3′/5′ UTR regions in transcripts were annotated by ESTs and/or cDNA
information, hypothetical protein could be predicted based on
encoding un-interrupted region on the transcript. This was the case
for one transcript (Abr-008, ENSMUST00000155035) of gene Abr
(ENSMUSG00000017631) (Fig. 3B). Its 5′ UTR was deﬁned by an EST
evidence (BB855312.1). However, one ORF event deﬁned by peptide
“GSEEGEPDASGGDDGGDCSDHDFEMVDLNEK” covered the non-cod-
ing exon (ENSMUSE00000840191) in the 5′ end of gene Abr.
Meanwhile, there was a typical domain, “Bcr-Abl oncoprotein
oligomerization domain”, for gene Abr imbedded in the new coding
region which provided a reasonable evidence for the elongation of the
coding region at 5′end. Moreover, the elongated coding sequences
could be supported by its homology in R. norvegicus (ref|NP_570111.
1|) and Sus scrofa (ref|NP_001038186.1|). In short, the newly deﬁned
ORF not only veriﬁed the translation of the exon at 5′ end, but also
gave a hint of new 5′ UTR waiting to be conﬁrmed in future.
Abr (ENSMUSG00000017631)
A
B
Fam172a (ENSMUSG00000064138)
Fig. 3. A) A coding region was discovered in an intron of gene Fam172a by inference from peptide “KNPWPKVDAHSGVLLQYNGMLEMNYYTVLFGVSR”. B) The 5′UTR of gene Abr could
be reﬁned by a novel ORF event inferred from a diagnostic peptide “KNPWPKVDAHSGVLLQYNGMLEMNYYTVLFGVSR”.
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events happened to “pseudogenes”. Some potential protein-coding genes
are only annotatedwith transcripts currently and lack of any evidence for
their translation, but proteogenomics method could improve such
annotation to protein level. Three genes annotated with “processed
transcript only” were reﬁned with translation proofs by our novel
diagnostic peptides (Supplementary Table 5). On the other hand, two
pseudogenes, “ENSMUSG00000083208” and “ENSMUSG00000083659”,
were conﬁrmed as protein-coding genes in our work (Supplementary
Table 5). Predictively, the former gene couldbeassociatedwithU6 snRNA,
and the latter could act as a eukaryotic initiation factor.
2.5.3. Intergenic events to discover novel protein-coding genes
In total 88 (51%) newly deﬁned ORF events located in the un-
annotated genome regions. About 37 novel ORF events could be cross
supported by other independent sources, namely 4 events from nr
homolog alignments, 5 events from ESTs libraries, 11 events from
possessing typical function domains and 34 events from RNA-seq
reads information (Supplementary Table 5). These newly deﬁned
ORFs could probably supply supplementary information to assist
modeling new genes by ab initio prediction tools. Using the coding
regions as hints to AUGUSTUS, we were able to predict 12 reasonable
genes each within the range of 1 Mb bp up- and down-stream of the
corresponding ORF (the median length of protein coding genes is
about 0.5 Mb bp in Ensembl database). One predicted gene with two
transcripts was located in the forward strand of chromosome
15:60320117-60350476. The hypothetical protein product (1470
aa) was much similar (95%) to one endonuclease/reverse transcrip-tase in mouse (gb|AAC53542.1|) with the function of DNase I-like
Endonuclease/exonuclease/phosphatase (Fig. 4A). There were 3 CDS
in one of the transcripts, and the third one was supported by the
newly deﬁned ORF. We found that this part of the predicted gene was
supported by evidences from ESTs library (Mus musculus, gb|
BU515235.1|; R. norvegicus, gb|CF111220.1|) and nr homology
alignments (R. norvegicus, ref|NP_787032.1|). It was similar to the
corresponding sequence of mouse gene Eef1a1 (eukaryotic transla-
tion elongation factor 1 alpha 1, chromosome 8), and contained the
typical domain for gene Eeﬂa1, “elongate translation factor”. It
seemed that the predicted gene was versatile. Another predicted
gene was located in the forward strain of chrX:98899612-98969253
with two transcripts (Fig. 4B). The predicted protein (~1100 aa)
possessed one function domain “UDP-N-acetylglucosamine”, which
was a typical domain for gene Ogt (O-linked N-acetylglucosamine
(GlcNAc) transferase). Though currently not supported by any other
independent evidence, proteomics conﬁdence of inferring this protein
was high: one newly deﬁned ORF was located in the 3′ end and 4
novel diagnostic peptides were located within it.
3. Discussion
We tried to discover novel protein-coding feature regions in
mouse genome by directly identifying natural peptides from multiple
mouse tandem mass spectrometry data. Since the encoding exons in
eukaryote genomes were interrupted by non-transcriptional introns,
the complex splicing procedure of assembling exons into transcripts
was the main mechanism of protein diversity compared with
Predicted gene (chr15:60320117-60350476)
Predicted gene (chrX:98899612-98969253)
A
B
Fig. 4. A) One predicted gene by AUGUSTUS was located in the forward strand of chr15:60320117-60350476. The newly discovered diagnostic peptide, “IGYNPDTVAFV-
SISGWSGDNMLEPSAKMLWFK”, was a proof to AUGUSTUS prediction. B) One predicted gene by AUGUSTUS was located in the forward strand of chrX:98899612-98969253. Four
novel diagnostic peptides were found to support AUGUSTUS prediction.
348 X.-B. Xing et al. / Genomics 98 (2011) 343–351prokaryote genomes. As a result, twomain tasks of eukaryote genome
annotation were to discover splicing events between two encoding
exons and to locate un-interrupted protein-coding regions on
chromosomes in the view of proteogenomics. Two diagnostic peptide
sequence datasets were constructed for this purpose in the current
work. The EJCT dataset (1,272,627 items) could be used to detect
splicing junctions between two encoded exons and ORF dataset
(81,371,189 items) to identify un-interrupted protein-coding regions
in the mouse genome. It is not for sure that these two datasets could
include all the protein-coding evens in mouse genome, but they are
certainly complementary in identifying novel peptides in our work, as
it was shown that for the 875 novel diagnostic peptides, 284 (32%)
were from EJCT dataset and 591 (68%) from ORF dataset without any
overlap. The coverage and diversity of gene annotation could also be
increased by building the two complementary diagnostic peptide
datasets. In total, 52 exon splicing events and 120 genic events could
be deﬁned by the novel peptides from EJCT dataset and from ORF
dataset respectively.
The peptides in the two datasets were theoretical and heteroge-
neous compared to well annotated full-length proteins in public
databases. Also, the numbers of items in the two datasets were much
larger than a typical mouse IPI dataset for proteomics search (55,303
protein sequences for IPI mouse v3.52). The above two situations
could cause a high degree of signal to noise ratio for peptide
identiﬁcation, but also allows for broad choices for discovering
potential un-annotated peptides in mouse proteome. Therefore series
of ﬁltration approaches were taken to reduce the redundancy and
noise from the diagnostic peptide datasets and obtain reliable novel
peptides. (See Materials and methods). The ﬁltered diagnostic
datasets were about half size of the original ones, yet nearly 80% of
identiﬁed peptides existed in both diagnostic datasets and the
Annotated dataset, which indicated high coverage and broad represen-tativeness of the constructed diagnostic datasets. In consideration of the
heterogeneity of EJCT and ORF dataset, a well annotated full-length
protein dataset (Annotated dataset) was constructed to be combined
with each dataset in the process of database search respectively, which
could reduce the possibility of mapping a spectrum to the suboptimum
peptide in EJCT/ORF dataset when otherwise it could best map to a well
deﬁned peptide. Actually, less than 100 candidate novel peptides were
in such cases (a spectrum matched two different peptides from
EJCT/ORF dataset and Annotated dataset respectively with both the
same E-value and hyper score but with different ppm), and they were
ﬁlteredout from theﬁnal results. Additionally, thepeptides existed both
in EJCT/ORF dataset and Annotated dataset could be directly treated as
known peptides, and the ones which were identiﬁed only in diagnostic
datasets were considered as novel candidates.
Genome annotation through proteomics strategy should always be
concerned of the error rate of spectra mapping to peptides, because of
much larger sequence database used than the typical one, as stated
above. Castellana et al. used a cutoff of 1% cumulative FDR at the
spectrum level to determine the conﬁdent peptides identiﬁed from
mass spectra data of Arabidopsis samples [11], and Fermin et al.
applied a hyper score receiver operator curve (ROC) to reduce the
false positive matches made by X!Tandem in detecting human novel
genes by proteogenomics [28]. We chose target/decoy strategy to
evaluate the quality of peptide identiﬁcation. It assumes that the
distribution of false matches to target sequences is identical to that of
matches to decoy peptides [26], and an ideal result of peptide search
could be that the peptides identiﬁed from decoy dataset only
randomly scattered at the bottom of the distribution of the peptides
identiﬁed from target dataset. In fact, with a relatively large
heterogeneous dataset as the query database in our work, setting
FDR~1% was not satisfactory to distinguish the decoy peptides from
the target ones since the hyper score distribution for the two datasets
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stricter empirical local FDR (b1e−6) at spectrum-level was applied to
ﬁlter out almost all the decoy peptides from the ﬁnal result (See
Materials and methods). As a result, instead of providing a much
larger volume of novel diagnostic peptides with possibly high false
positive rates, we chose to analyze relatively less but more conﬁdent
novel peptides for the subsequent genome annotation.
After the FDR control, the peptides identiﬁed only from diagnostic
datasets could still contain false positives derived from several other
sources. Differences of peptide sequences could stem from non-
synonymous coding single nucleotide polymorphisms, the processes
of the local FDR control, EJCT database construction, and the same
molecular weight of Ile and Leu. All these kinds of false positives could
be detected by blasting with the Annotated dataset, and then were
ﬁltered out from the ﬁnal result. Eventually, we conﬁdently identiﬁed
875 novel diagnostic peptides (284 from EJCT dataset and 591 from
ORF dataset) with 2256 spectra. The peptides whichwere identiﬁed at
least twice (176 peptide, 20%) were used to infer 172 genic events at
genome level.
Genome annotation is more considered as a systematic project
which requires and integrates multiple levels of gene related
information. Each level of knowledge on gene is fundamentally
based on the genome sequences but establishes and develops on its
own system. As for their contribution to the discovering process of
protein-coding genes, each possesses pros and cons. Conﬁrmation of
most protein-coding genes in eukaryotes used to look for transcript
deposits, such as in ESTs library, or now in mRNA-seq data. However
intrinsic problems such as sequencing error and chimerism are well
aware of [30], besides, transcript proof can't determine the ultimate
existence of protein products. Some ab initio gene prediction tools are
greatly helpful in modeling genes in completely un-know genome
regions. They work well in prokaryotes, but show low accuracy in
eukaryotes due to the complex intron/exon gene model and further
alternative splicing events. Deﬁning protein-coding regions in
eukaryotes by aligning peptides back to genome as proteogenomics
does partially solves the problemsmentioned above. The advantage of
proteogenomics is that it can integrate protein peptide evidences,
along with other related information in gene level or RNA level.
Nevertheless four other independent sources were made used of in
our work, i) transcript evidences from ESTs library, splicing
microarray data, mRNA-seq data, ii) nr database for homolog
information, iii) gene prediction in silicon by AUGUSTUS, and
iv) function domain prediction by InterProScan [31], to supply more
hints on the newly discovered events in genome. The homolog
evidences from M. mulatta (ref|XP_002804798.1|) and C. jacchus (ref|
XP_002753452.1|) supported the new splicing junction between two
exons (ENSMUSE00000684431 and ENSMUSE00000348770) in
mouse gene Eif3j, and the transcript evidence was also helpful to
link them together. Since the gene was only annotated with one
protein product (ENSMUSP00000028668) in Ensembl and one non-
translation transcript, the integration of multiple independent
evidences, especially the peptides from EJCT dataset, could reﬁne
the gene annotation of Eif3j by giving a strong hint of a new protein-
coding transcript. The integration also worked well in the example of
revising gene boundary of Abr. The 5′ end of Abr was previously
determined by an EST evidence (BB855312.1). A novel deﬁned ORF
event in our work could probably revise the previous 5′ UTR into
encoding feature and lengthen the coding region. The elongation was
supported by homolog evidence of R. norvegicus (ref|NP_570111.1|)
and S. scrofa (ref|NP_001038186.1|), and domain prediction with
translated ORF obtained a typical function domain for Abr. All of these
could partly support the elongation, however, to deﬁne the exact
boundary of 5′ end of gene Abr need other information in future. The
initial step for ab initio gene prediction tools is to deﬁne the boundary
of encoding exons frequently using sequence patterns such as
acceptor splice site (required AG consensus) and donor splice site(required GT consensus). The predicted results usually contain
numerous candidate coding regions since only about 1% genome
region is encoded in mouse genome.
Proteogenomics strategy could supply the coding boundaries
deﬁned by identiﬁed peptides as hints to improve the accuracy for
prediction tools. As we did in our work, 12 novel genes were predicted
by AUGUSTUS which covered 16 novel diagnostic peptides. Some
predicted genes could function similarly as known genes, such as
predicted gene chr15:60320117-60350476 possessing the similar
typical domain like gene DNaseII and Eef1a1. But for some predicted
genes (e.g. predicted gene chrX:98899612-98969253), we could not
get any information currently other than its protein sequence, further
analyses are needed to explore its function.
4. Conclusion
In this work, proteogenomics strategy was applied on mouse mass
spectrometry data to discover novel protein-coding regions and
amend genome annotation. Two distinctive proteomic searchable
datasets were constructed and queried with multi-origin mouse
sample tandem mass spectra, in order to identify diagnostic peptides
characterizing novel exon junction transcript variants and un-
annotated exon-coding regions in mouse genome. Fifty two splice
events and 120 ORF events were deﬁned as novel in comparison with
mouse genome annotation. After integrating information from other
independent sources, such as ESTs library, microarray and mRNA-seq
data, homology information, domain prediction analysis, some gene
models were reﬁned and a series of novel protein coding regions were
deﬁned. Our work proved the applicability of proteogenomics
approach on a complex eukaryotic model organism, and the
knowledge gained on the reﬁnement of mouse genome annotation
events is beneﬁcial. With more in-depth mass spectrometry data
generated, and proteogenomics strategy improved, more rounds of
protein to gene cross-validation will happen and eventually bring
wholesome gene model conﬁrmation and reﬁnement.
5. Materials and methods
5.1. Tandem mass spectrometry data generation from mouse samples
All the 494 raw ﬁles were generated by our own experiments. For
the large-scale phosphoproteome analysis of 3T3-L1 adipocyte
differentiation (279 raw ﬁles) and mature cells (105 raw ﬁles), the
detailed experimental procedures have been described elsewhere
[32,33] with some modiﬁcations. Brieﬂy, the whole process included
cell culture with the stable isotope labeling by amino acids in cell
culture (SILAC) strategy, differentiation induction stimulated with
insulin, 3-isobutyl-1-methylxanthine, and dexamethasone for 0, 5, 15,
30, 60, and 120 min (differentiation), 0, 5, and 10 min (mature), and
proteome analyses with online yin-yang multidimensional liquid
chromatography (MDLC)-MS/MS system [22] on linear ion trap
(LTQ)-Orbitrap hybrid mass spectrometer (ThermoFisher Scientiﬁc,
San Jose, CA). The NSI nanospray source was mounted and the voltage
was set at 1.90 kV. Normalized collision energy was 35%. The data-
dependent collection of the ten most intense ions with collision-
induced dissociation from each full scan (performed in Orbitrap) was
selected for MS2 analyses (performed in ion-trap). Dynamic exclusion
settings: repeat count 2, repeat duration 30 s, and exclusion duration
90 s. The resolution of the Orbitrap mass analyzer was set at 100, 000
(m/z 400) for the precursor ion scans. For the in-depth phosphopro-
teome data set from mES cells (80 raw ﬁles), the complete work ﬂow
has been stated recently [34]. In addition, phosphoproteome
investigation of mouse tissues (liver, muscle and brain) was
performed on MDLC-MS/MS platform aforementioned, in which 30
raw ﬁles were obtained in total.
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The competitive Annotated dataset included 68,305 mouse
annotated protein sequences from public protein databases of NCBI
RefSeq [20], Ensembl proteins [18] and EBI-IPI proteins [21]. Proteins
with identical sequences from the three sources were recorded as one
protein entry.5.3. The EJCT (Exon JunCTion) dataset construction
The 260,804 mouse protein coding exon sequences were down-
loaded from Ensembl Biomart (Ensembl gene 59) in FASTA format. All
the exons located in one Ensembl gene were ordered from 5′ end to 3′
endby their chromosome loci (Supplementary Fig. 1). Theexon closer to
5′ end of the gene was in succession joined with each exon closer to 3′
end of the gene without regarding exon phases (The exon phase
indicates the positionwhere the coding feature beginswith reference to
the reading frame. The phase is one of the integers 0, 1, or 2, indicating
the number of bases that should be removed from the beginning of this
exon to reach the ﬁrst base of the next codon). The DNA sequence
around junction site between each two exonswas intercepted for 90 bp
sequence, and then the 180 bp junction DNA sequencewas three-frame
translated into three theoretical peptide sequences respectively. In the
case that exon lengthwas shorter than 90 bp, thewhole exon sequence
was included. The peptide was included into EJCT dataset in FASTA
format with the two exon identiﬁers and the frame as the header
information only if i) it didn't contain any gap, ii) its length was longer
than 6 aa, iii) it contained Lysine (K) or Arginine (R) of trypsin catalytic
sites, iv) the chromosome coordinate was unique when it was aligned
backwards to the genome and v) the entry of its sequence was not the
same as its reversal. The EJCT dataset eventually contained 1,272,627
non-ambiguous peptide sequences.5.4. The ORF (Open Reading Frame) dataset construction
The completemouse genome (NCBI Build 37)was downloaded from
the NCBI Genome site in FASTA format. The genomewas translated into
putative ORF peptide sequence as previously [28]. The peptide was
included into ORF dataset with its chromosome locus as the header
information only if i) its length was longer than 6 aa, ii) it contained
Lysine (K) or Arginine (R) of trypsin catalytic sites, iii) the genomic locus
was unique when it was aligned backwards to the genome and iv) the
entry of its sequence was not the same as its reversal. The ORF dataset
eventually contained 81,371,189 non-ambiguous peptide sequences.5.5. Database search with X!Tandem and local FDR control
All the 494 raw ﬁles were converted into mzXML format ﬁles and
analyzed by X!Tandem software [25]. The target/decoy strategy was
used to build the input search databases for X!Tandem [26]. The
EJCT/ORF databases were comprised of EJCT/ORF dataset (target
database) and competitive Annotated dataset along with the reversed
sequences of the two datasets as the decoy databases. Search
parameters were set as following: Fragment monoisotopic mass
error=0.4 Da, Parent monoisotopic mass error=±20 ppm, Maxi-
mummissed cleavage sites=1 andModiﬁcation mass=57.022 Da@-
cystine. All runs were performed on 96 nodes of Linux x86_64
platform. The 494 XML output ﬁles from X!Tandem analysis in
EJCT/ORF dataset were parsed using Perl scripts. Each XML result was
divided into peptide charge bins, of each charge bin only the spectrum
with one unique candidate peptide was used to control the local FDR
(2∗No. of Decoy(spectra)/(No. of Target(spectra)+Decoy(spectra)))
less than 1e−6.5.6. Filtering of false positives from candidate novel diagnostic peptides
Possible known peptides (false positives) in total of 1285
candidate novel diagnostic peptides were further ﬁltered out by
blastingwith the Annotated dataset. These false positives could derive
from i) non-synonymous coding single nucleotide polymorphisms of
the same gene, yet the correlated peptides of which could be
discriminated by X!Tandem because of molecular weight differences;
ii) equal local FDR control, which could remove peptides with
relatively low hyper scores in one mzXML ﬁle, but not the ones
with high hyper scores in othermzXML ﬁles; iii) the interception of 60
aa length for peptides in EJCT dataset, whichmight allow fragments of
60 aa-length peptides with corresponding enzymatically full-length
peptides being also identiﬁed (Supplementary Fig. 1); and iv) the
inherent ﬂaw of searching engines not being able to discriminate the
same molecular weight between Ile and Leu in peptide sequences.
When the comparison mismatch between the candidate novel
diagnostic peptide and its corresponding Annotated peptide of the
highest blast similarity was less than or equal to 2 aa, it was deﬁned as
false positive and ﬁltered out.
5.7. Diagnostic peptides cross-supported by mouse transcript data
The mouse transcripts data were collected from EST libraries in
NCBI, mRNA-seq data [3] (The work mapped the transcriptomes of
mouse brain, liver and muscle tissues by deep sequencing) and
splicing microarray data [4] (The work used microarray platform to
quantity tissue-speciﬁc alternative splicing events in major mouse
tissues). All our identiﬁed 875 novel diagnostic peptides were aligned
to EST libraries and microarray splicing evidences with tblastn
algorithms. The local perfect alignment between transcript evidences
and novel peptides from EJCT dataset should include at least 3 amino
acids from each peptide adjoining the junction site. Peptides with less
than 2 mismatches were annotated to be with “transcript support”.
The mouse RNA-Seq data was downloaded from http://woldlab.
caltech.edu/rnaseq/. The BED ﬁles of the reads from all the samples
were compared to the coordinates of the novel peptides using
BEDTools [35]. The uniquely and multiply mapped RNA-Seq reads
whose coordinates overlapped at least one nucleotide with that of
novel ORF peptides were considered as the evidence of peptides on
the transcript level (As for cross supporting genic events, we required
at least two RNA reads being imbedded in the encoding region). The
coordinates of exon-junctions mapped by RNA-Seq reads were
compared with that of novel peptides from EJCT dataset using
BEDTools and a custom Perl script. The RNA-Seq reads were
considered supportive to the novel peptides when their exon-junction
sites were the same.
5.8. Cross comparison of novel peptides
Recently, Brosch M et al. published a similar work, using shotgun
proteomics to aid discovery of novel protein-coding events on mouse
genome [19]. They supplied 68 newly identiﬁed peptides. In our work,
we totally identiﬁed 875 novel peptides for mouse proteome. Two
steps were taken to compare our results with Broach's work. Firstly,
the two sets of novel peptides were blast against each other directly
(blastp parameters, E-value: 1e−5 and match coverage: 95%).
Secondly, the correlating chromosome positions of the two sets of
novel peptides on mouse genome were mapped. As a result, only one
peptide was shared that map to the same chromosome position on
mouse genome, “DPFAELSLEDFL” in our work and “AAGKDPFAEL-
SLEDFL” in Brosch et al. work.
In addition, we performed overlap comparison between our results
and the latest version of mouse protein databases, which were not
available in our original analysis. We downloaded the M. musculus
protein sequences from both Ensembl Mus_musculus.NCBIM37.63 and
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and mis-match was set at less than 2. The ﬁnal results showed that two
of our identiﬁed novel peptides, one from EJCT dataset “SIFSGIDGLS-
SADPSSDWNAPAEEWGNWVDEDR”, the other from ORF dataset
“MASNFIGNSTAIQELFK”, are now incorporated as peptide “SIFSGIDGLS-
SADPSSDWNAPAEEWGNWVDEDR” in current ENSMUSP00000130190,
and peptide “MASTFIGNSTAIQELFK” in current ENSMUSP00000130756,
respectively.
5.9. Genic domain prediction
InterProScan was used to scan and predict protein domains based
on sequence [31]. The full-length peptides of the two adjacent exons
which contained novel diagnostic peptides from EJCT dataset were
used as the input. The predicted domain region should include at least
5 amino acids at each side of the junction site of the two exons. The
results are listed in Supplementary Table 6. The full-length ORF
sequences which contained novel diagnostic peptides from ORF
dataset were also used as the input for InterProScan and the predicted
protein domains are provided in Supplementary Table 7.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ygeno.2011.07.005.
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